Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma
Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the aver...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1994 |
|---|
| Umfang: |
5 |
|---|
| Reproduktion: |
Springer Online Journal Archives 1860-2002 |
|---|---|
| Übergeordnetes Werk: |
in: Journal of hepato-biliary-pancreatic surgery - 1993, 1(1994) vom: März, Seite 252-256 |
| Übergeordnetes Werk: |
volume:1 ; year:1994 ; month:03 ; pages:252-256 ; extent:5 |
| Links: |
|---|
| Katalog-ID: |
NLEJ207611084 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ207611084 | ||
| 003 | DE-627 | ||
| 005 | 20210706233056.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 070528s1994 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)NLEJ207611084 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| 264 | 1 | |c 1994 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). | ||
| 533 | |f Springer Online Journal Archives 1860-2002 | ||
| 700 | 1 | |a Nakao, Akimasa |4 oth | |
| 700 | 1 | |a Harada, Akio |4 oth | |
| 700 | 1 | |a Nonami, Toshiaki |4 oth | |
| 700 | 1 | |a Kaneko, Tetsuya |4 oth | |
| 700 | 1 | |a Inoue, Soichiro |4 oth | |
| 700 | 1 | |a Takagi, Hiroshi |4 oth | |
| 773 | 0 | 8 | |i in |t Journal of hepato-biliary-pancreatic surgery |d 1993 |g 1(1994) vom: März, Seite 252-256 |w (DE-627)NLEJ188990674 |w (DE-600)1473162-9 |x 1436-0691 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:1994 |g month:03 |g pages:252-256 |g extent:5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/BF02391076 |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-SOJ | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 1994 |c 3 |h 252-256 |g 5 | ||
| matchkey_str |
article:14360691:1994----::nroeaieaiteayorscaladneetbe |
|---|---|
| hierarchy_sort_str |
1994 |
| publishDate |
1994 |
| allfields |
(DE-627)NLEJ207611084 DE-627 ger DE-627 rakwb eng Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma 1994 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). Springer Online Journal Archives 1860-2002 Nakao, Akimasa oth Harada, Akio oth Nonami, Toshiaki oth Kaneko, Tetsuya oth Inoue, Soichiro oth Takagi, Hiroshi oth in Journal of hepato-biliary-pancreatic surgery 1993 1(1994) vom: März, Seite 252-256 (DE-627)NLEJ188990674 (DE-600)1473162-9 1436-0691 nnns volume:1 year:1994 month:03 pages:252-256 extent:5 http://dx.doi.org/10.1007/BF02391076 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 1 1994 3 252-256 5 |
| spelling |
(DE-627)NLEJ207611084 DE-627 ger DE-627 rakwb eng Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma 1994 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). Springer Online Journal Archives 1860-2002 Nakao, Akimasa oth Harada, Akio oth Nonami, Toshiaki oth Kaneko, Tetsuya oth Inoue, Soichiro oth Takagi, Hiroshi oth in Journal of hepato-biliary-pancreatic surgery 1993 1(1994) vom: März, Seite 252-256 (DE-627)NLEJ188990674 (DE-600)1473162-9 1436-0691 nnns volume:1 year:1994 month:03 pages:252-256 extent:5 http://dx.doi.org/10.1007/BF02391076 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 1 1994 3 252-256 5 |
| allfields_unstemmed |
(DE-627)NLEJ207611084 DE-627 ger DE-627 rakwb eng Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma 1994 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). Springer Online Journal Archives 1860-2002 Nakao, Akimasa oth Harada, Akio oth Nonami, Toshiaki oth Kaneko, Tetsuya oth Inoue, Soichiro oth Takagi, Hiroshi oth in Journal of hepato-biliary-pancreatic surgery 1993 1(1994) vom: März, Seite 252-256 (DE-627)NLEJ188990674 (DE-600)1473162-9 1436-0691 nnns volume:1 year:1994 month:03 pages:252-256 extent:5 http://dx.doi.org/10.1007/BF02391076 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 1 1994 3 252-256 5 |
| allfieldsGer |
(DE-627)NLEJ207611084 DE-627 ger DE-627 rakwb eng Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma 1994 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). Springer Online Journal Archives 1860-2002 Nakao, Akimasa oth Harada, Akio oth Nonami, Toshiaki oth Kaneko, Tetsuya oth Inoue, Soichiro oth Takagi, Hiroshi oth in Journal of hepato-biliary-pancreatic surgery 1993 1(1994) vom: März, Seite 252-256 (DE-627)NLEJ188990674 (DE-600)1473162-9 1436-0691 nnns volume:1 year:1994 month:03 pages:252-256 extent:5 http://dx.doi.org/10.1007/BF02391076 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 1 1994 3 252-256 5 |
| allfieldsSound |
(DE-627)NLEJ207611084 DE-627 ger DE-627 rakwb eng Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma 1994 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). Springer Online Journal Archives 1860-2002 Nakao, Akimasa oth Harada, Akio oth Nonami, Toshiaki oth Kaneko, Tetsuya oth Inoue, Soichiro oth Takagi, Hiroshi oth in Journal of hepato-biliary-pancreatic surgery 1993 1(1994) vom: März, Seite 252-256 (DE-627)NLEJ188990674 (DE-600)1473162-9 1436-0691 nnns volume:1 year:1994 month:03 pages:252-256 extent:5 http://dx.doi.org/10.1007/BF02391076 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 1 1994 3 252-256 5 |
| language |
English |
| source |
in Journal of hepato-biliary-pancreatic surgery 1(1994) vom: März, Seite 252-256 volume:1 year:1994 month:03 pages:252-256 extent:5 |
| sourceStr |
in Journal of hepato-biliary-pancreatic surgery 1(1994) vom: März, Seite 252-256 volume:1 year:1994 month:03 pages:252-256 extent:5 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Journal of hepato-biliary-pancreatic surgery |
| authorswithroles_txt_mv |
Nakao, Akimasa @@oth@@ Harada, Akio @@oth@@ Nonami, Toshiaki @@oth@@ Kaneko, Tetsuya @@oth@@ Inoue, Soichiro @@oth@@ Takagi, Hiroshi @@oth@@ |
| publishDateDaySort_date |
1994-03-01T00:00:00Z |
| hierarchy_top_id |
NLEJ188990674 |
| id |
NLEJ207611084 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ207611084</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706233056.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1994 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ207611084</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%).</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nakao, Akimasa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harada, Akio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nonami, Toshiaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaneko, Tetsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Inoue, Soichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Takagi, Hiroshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Journal of hepato-biliary-pancreatic surgery</subfield><subfield code="d">1993</subfield><subfield code="g">1(1994) vom: März, Seite 252-256</subfield><subfield code="w">(DE-627)NLEJ188990674</subfield><subfield code="w">(DE-600)1473162-9</subfield><subfield code="x">1436-0691</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1994</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:252-256</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF02391076</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1994</subfield><subfield code="c">3</subfield><subfield code="h">252-256</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| series2 |
Springer Online Journal Archives 1860-2002 |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ188990674 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1436-0691 |
| topic_title |
Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a n an a h ah t n tn t k tk s i si h t ht |
| hierarchy_parent_title |
Journal of hepato-biliary-pancreatic surgery |
| hierarchy_parent_id |
NLEJ188990674 |
| hierarchy_top_title |
Journal of hepato-biliary-pancreatic surgery |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ188990674 (DE-600)1473162-9 |
| title |
Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| spellingShingle |
Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| ctrlnum |
(DE-627)NLEJ207611084 |
| title_full |
Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| journal |
Journal of hepato-biliary-pancreatic surgery |
| journalStr |
Journal of hepato-biliary-pancreatic surgery |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1994 |
| contenttype_str_mv |
zzz |
| container_start_page |
252 |
| container_volume |
1 |
| physical |
5 |
| format_se |
Elektronische Aufsätze |
| title_sort |
intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| title_auth |
Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| abstract |
Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). |
| abstractGer |
Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). |
| abstract_unstemmed |
Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%). |
| collection_details |
GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE |
| title_short |
Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma |
| url |
http://dx.doi.org/10.1007/BF02391076 |
| remote_bool |
true |
| author2 |
Nakao, Akimasa Harada, Akio Nonami, Toshiaki Kaneko, Tetsuya Inoue, Soichiro Takagi, Hiroshi |
| author2Str |
Nakao, Akimasa Harada, Akio Nonami, Toshiaki Kaneko, Tetsuya Inoue, Soichiro Takagi, Hiroshi |
| ppnlink |
NLEJ188990674 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| up_date |
2024-07-06T10:09:55.099Z |
| _version_ |
1803823973768626176 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ207611084</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706233056.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1994 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ207611084</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Eighty patients with pancreatic carcinoma were treated by intraoperative radiotherapy (IORT) with or without surgical resection of the tumor, and the results were compared with those of 111 patients treated by surgery alone. For resectable patients, the radiation dose was 30 Gy and the average field sizes were 8 or 10 cm; for unresectable patients, these values were 20–30 Gy and 6 or 8 cm, respectively. No side effects of IORT were observed. In 49 resectable stage III patients, the IORT group (n=16) had a higher survival rate than the non-IORT group (n=33); i.e., 1-year survival rates of 44.6% vs 23% and 2-year survival rates of 37.2% vs 7.7% after surgery (P<0.05). However, there was no significant difference in survival rate between the IORT group (n=28) and the non-IORT group (n=29) in 57 resectable patients in stage IV. In unresectable patients, the IORT group (n=31) (P<0.05) had a higher survival rate than the non-IORT group (n=38) (P<0.05). The palliative effect of IORT on abdominal or back pain was evaluated in 15 patients who had such symptoms and did not undergo tumor resection. Overall, pain decreased or disappeared in 13 of these patients (87%).</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nakao, Akimasa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harada, Akio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nonami, Toshiaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaneko, Tetsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Inoue, Soichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Takagi, Hiroshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Journal of hepato-biliary-pancreatic surgery</subfield><subfield code="d">1993</subfield><subfield code="g">1(1994) vom: März, Seite 252-256</subfield><subfield code="w">(DE-627)NLEJ188990674</subfield><subfield code="w">(DE-600)1473162-9</subfield><subfield code="x">1436-0691</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1994</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:252-256</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF02391076</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1994</subfield><subfield code="c">3</subfield><subfield code="h">252-256</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| score |
7.400508 |